Electronystagmography testing is a diagnostic test used to record spontaneous eye activities. Electronystagmography testing can be used to identify the cause of dizziness, balance dysfunction, and vertigo by testing the vestibular system. Electronystagmography testing is used to detect even the slightest movement of the eyes. The electronystagmography testing is done by using disc electrodes which are attached around the nose and electrical leads of discs electrode are connected to an oscilloscope to measure the spontaneous eye movement.
Request Sample https://www.factmr.com/connectus/sample?flag=S&rep_id=2273
In electronystagmography testing, the movement of the eye is accurately recorded because the cornea is electropositive and retina is electronegative due to which these electrodes accurately record the spontaneous movement of the eye. Basically, electronystagmography testing consists of series of diagnostic tests including Videonystagmography, Rotary Chair Test, Computerized Dynamic Visual Acuity (DVA), Computerized Dynamic Posturography (CDP), Subjective Visual Vertical, and Vestibular Evoked Myogenic Potential (VEMP). Videonystagmography test (VNG test) records the eye movement in a dark, as well as light room with the help of a video camera, mounted inside the goggles that are worn during testing.
Tentatively, the global electronystagmography testing market can be segmented on the basis of test type, indication, end user, and geography.
Based on the test type, the global electronystagmography testing market is segmented into:
Based on the indication, the global electronystagmography testing market is segmented into:
Based on the end user, the global electronystagmography testing market is segmented into:
Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=2273
The global electronystagmography testing market is highly fragmented owing to the presence of a large number of domestic manufacturers. Examples of some of the key players operating in the global electronystagmography testing market are
Request ToC https://www.factmr.com/connectus/sample?flag=T&rep_id=2273
The increasing number of inner ear disorders that cause vertigo is likely to boost the demand for electronystagmography testing market. Also, increasing healthcare spending, better infrastructure, and reimbursement facilities are expected to be the major factors driving the growth of the electronystagmography testing market over the forecast period.
However, limited awareness about related disorders in the developing nations, the high cost of the tests & devices, and availability of cheap alternatives in the market are expected to be the major restraining factors for the growth of the electronystagmography testing market.
For More Insights- https://www.einpresswire.com/article/556337411/infrastructure-safety-to-ramp-up-demand-for-ultrasonic-pulse-velocity-testing-fact-mr
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Written By
The autologous fat grafting market is anticipated to witness substantial growth, with a robust compound annual growth rate (CAGR) of nearly 10% during the period from 2021 to 2031. Among various applications, breast augmentation emerges as the dominant segment, capturing a significant market share of over 45%. Autologous Fat Grafting, also known as fat transfer or lipofilling, has emerged as a ...
The osseointegration implants market is projected to witness substantial growth, with an estimated valuation of US$ 2.52 billion by the year 2022. Furthermore, this market is anticipated to expand at a robust compound annual growth rate (CAGR) of 8% and reach a sig...
The projected valuation of the trauma care centres market is estimated to reach USD 28.58 billion by the year 2032, reflecting a compound annual growth rate (CAGR) of 7.50% during the period from 2022 to 2032. Furthermore, it is anticipated that the market value of...
The drug discovery technologies market is projected to generate a revenue of US$ 59 billion in 2022, with an estimated growth to reach US$ 81.5 billion by the conclusion of 2026. This anticipated expansion is attributed to the global demand for drug discovery techn...